Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Clinical trial NCT07187479 · RECRUITING

Trial details

NCT number: NCT07187479
Sponsor: Well Cell Global
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Kidney Disease (Stages 4 and 5)Kidney Disease Type 2 Diabetes

Start date: 2025-10-14
Primary completion: 2026-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.